NOTCH1 and neuroblastoma: Kim et al. [34] found that NOTCH signaling was enhanced in GSK-3 double-knockout mice, whereas another study [35] found that GSK-3β inhibition leads to decreased NICD levels in neuroblastoma cells and decreased vascular smooth-muscle cell proliferation and survival.